|
|
||||||||
1 Department of Medical Physics, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands; and 2 Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia 22906-0011
| |
ABSTRACT |
|---|
|
|
|---|
We
previously reported that a 0.4- to 0.5-µm-thick endothelial surface
layer confines Dextran 70 (70 kDa) to the central core of hamster
cremaster muscle capillaries. In the present study we used a variety of
plasma tracers to probe the barrier properties of the endothelial
surface layer using combined fluorescence and brightfield intravital
microscopy. No permeation of the endothelial surface layer was observed
for either neutral or anionic dextrans
70 kDa, but a neutral Dextran
40 (40 kDa) and neutral free dye (rhodamine, 0.4 kDa)
equilibrated with the endothelial surface layer within 1 min. In
contrast, small anionic tracers of similar size (0.4-40 kDa)
permeated the endothelial surface layer relatively slowly with
half-times (
50) between 11 and 60 min, depending on
tracer size. Furthermore, two plasma proteins, fibrinogen (340 kDa) and
albumin (67 kDa), moved slowly into the endothelial surface layer at
the same rates, despite greatly differing sizes (
50
40 min). Dextran 70, which did not enter the glycocalyx over the course
of these experiments, entered at the same rate as free albumin when it
was conjugated to albumin. These findings
demonstrate that for anionic molecules size and charge have a profound
effect on the penetration rate into the glycocalyx. The equal rates of penetration of the glycocalyx demonstrated by the different
protein molecules suggests that multiple factors may influence the
penetration of the barrier, including molecular size, charge, and structure.
intravital microscopy; capillaries; endothelium; glycocalyx; solute barrier
| |
INTRODUCTION |
|---|
|
|
|---|
EXCHANGE OF SUBSTRATE from blood to tissue entails
solute transport across the endothelial lining of blood vessels. A
molecule diffusing from plasma to interstitium must traverse both the
endothelial cell surface glycocalyx and the pericellular junctions of
the endothelium. Although considerable attention has been paid to passive and active mechanisms that enable molecules to traverse endothelial cells, little is known about the permeability
characteristics of the endothelial surface layer, i.e., the endothelial
cell glycocalyx including associated plasma proteins.
Functional studies and electron-microscopic observations of endothelial
surface structures suggest that the endothelial surface layer is an
important determinant of solute exchange (3, 4, 9, 11, 14, 15).
However, measurement of permeation of plasma solutes into the
endothelial surface layer was not made until recently when we (15)
demonstrated that the in vivo barrier properties of the endothelial
surface layer can be studied using intravital microscopy. By observing
labeled tracer molecules and the capillary endothelium using a
combination of fluorescence and brightfield microscopy, estimates can
be obtained of the luminal distribution of circulating solutes relative
to the location of the luminal endothelial cell membrane. Injected solute initially fills a core plasma volume and then invades a circumferential annulus. The rate at which solute approaches the luminal endothelial surface can be accurately determined by repeated observations over time following intravenous injection of a bolus of
fluorescent tracer (Fig. 1).
|
| |
MATERIAL AND METHODS |
|---|
|
|
|---|
In this study we used a variety of molecules of different size, charge, and molecular structure to probe the permeability characteristics of the endothelial surface layer. Free fluorescent dyes and fluorescently labeled dextrans of various molecular masses (4-2,000 kDa) were administered to establish a size and charge dependence of solute permeation rates into the endothelial surface layer. To test for a charge dependence of permeability, neutral dextrans were labeled with either Texas Red (Texas Red, neutral) or FITC (anionic). Finally, two critical plasma proteins (albumin and fibrinogen) as well as a protein-dextran complex (albumin-Dex 70) were injected, and permeation rates were compared with dextrans of similar molecular mass and charge.
Animal Preparation
All procedures and the care of animals were in accordance with institutional guidelines. Male Syrian golden hamsters (934 capillaries observed in 46 animals, mean weight ± SD = 112 ± 12 g, mean age ± SD = 6.6 ± 0.7 wk) were anesthetized with pentobarbital sodium (70 mg/kg body wt ip), and the trachea was cannulated to ensure a patent airway. The left femoral vein was cannulated for continuous infusion of 0.9% saline (0.5 ml/h) containing 10 mg/ml pentobarbital sodium and for bolus injection of fluorescent tracers (see Fluorescent Tracers). The hamster was placed on a Plexiglas platter, and the right cremaster muscle was prepared for visualization of the microcirculation as previously described. The cremaster muscle was continuously superfused at 5 ml/min with a bicarbonate-buffered physiological salt solution consisting of (in mM) 131.9 NaCl, 4.6 KCl, 2.0 CaCl2, 1.2 MgSO4, and 20 NaHCO3. The superfusion solution was gas equilibrated with 5% CO2-95% N2 to obtain a pH of 7.35-7.45, and the solution was maintained at 34°C. Succinylcholine (10
5 M, Sigma) was added
to the superfusion solution to reduce spontaneous skeletal muscle
contractions. The body temperature of the hamster was maintained at
37-38°C with conducted heat.
Fluorescent Tracers
To determine the permeability of the endothelial surface coat, fluorescently labeled tracer molecules were injected via the femoral venous cannula. All tracers were dissolved in normal saline (20 mg/ml) and injected as a bolus (0.3-0.4 ml) 45-60 min after completion of the surgical preparation of the cremaster muscle.Anionic dextrans. Anionic dextrans, i.e., dextrans conjugated with FITC, were used to probe the porosity of the endothelial surface layer. FITC-dextrans of 4 (34 capillaries in 2 animals), 17 (45 capillaries in 2 animals), 39 (95 capillaries in 2 animals), 70 (42 capillaries in 9 animals), 580 (75 capillaries in 3 animals), and 2,000 kDa (88 capillaries in 2 animals) were used. All FITC-dextrans were supplied by Sigma. The net charges on these molecules varies from batch to batch, but according to the distributor there are roughly 0.01 FITC molecules/glucose residue. Accordingly, the net charge on the dextrans would be proportional to molecular mass ranging from slightly less than 1/dextran to slightly more than 100 for the 2,000-kDa molecule. Therefore, the variation in penetration rate of the glycocalyx for these molecules represents changes in both size and charge.
Neutral dextrans. Neutral dextrans (i.e., dextrans labeled with Texas Red) of 40 (57 capillaries in 3 animals) and 70 kDa (35 capillaries in 1 animal), respectively, were also used. Dextrans conjugated with Texas Red dye were obtained from Molecular Probes.
Proteins. Bovine serum albumin [Sigma A-2934, molecular mass (mol. mass) 67 kDa] and fibrinogen (Sigma F-8630, mol. mass 340 kDa) were labeled with the fluorescein derivative dichlorotriazinylaminofluorescein dihydrochloride (DTAF). These were used in 91 capillaries in four animals and 104 capillaries in five animals, respectively. Two additional fibrinogen experiments were performed using FITC-fibrinogen (69 capillaries in 2 animals) that was kindly provided by the American Red Cross. DTAF was obtained from Research Organics Albumin conjugated with Dextran 70 (FITC-labeled albumin-Dex 70 complex, mol. mass ~136 kDa, 50 capillaries in 1 animal) was custom made by Molecular Probes.
Free dyes. Two anionic dyes, fluorescein (mol. mass 376 Da, 52 capillaries in 3 animals) and DTAF (mol. mass 568 Da, 54 capillaries in 3 animals), and one neutral dye, rhodamine (mol. mass 479, 10 capillaries in 3 animals), were injected systemically as free dyes to test for possible (charge dependent) exclusion of these small molecules by the endothelial surface coat. In three animals, two different dyes were present together, allowing for the simultaneous observation of rhodamine (3 capillaries) in the presence of fluorescein, rhodamine (2 capillaries) in the presence of DTAF, and Texas Red-labeled Dextran 40 (9 capillaries) in the presence of DTAF-albumin.
Intravital Microscopy
Microvessels of the cremaster muscle were observed with an intravital microscope (Zeiss ACM) and an SIT video camera (model 66, DAGE MTI). For brightfield observations, the hamster cremaster muscle was transilluminated with a 150-W xenon lamp. Epifluorescence observations were made using a xenon high-pressure lamp (75 W). All preparations were examined at ×90 [Leitz, water immersion, numerical aperture (NA) 1.20]. A ×20 objective (Leitz, NA 0.33) acted as a long-working distance transillumination condenser. Brightfield measurements were made with a 450- to 490-nm bandpass interference filter (blue light) in the light path; fluorescent FITC- and DTAF-associated molecules were observed using Zeiss fluorescence packages for fluorescein and rhodamine. Fluorescein samples were observed with an excitation filter (450-490 nm), a dichroic beam splitter (FT 510), and a long-pass filter (LP 520) in the excitation/emission pathway. Rhodamine and Texas Red were observed using an excitation filter (510-560 nm), a dichroic mirror (FT 580), and a long-pass filter (LP 590). The image was displayed on an MTI video monitor (Dage), and experiments were recorded on videotape using a Panasonic S-VHS videocassette recorder for further image analysis. Measurements were made as described previously (15).Data Analysis
Video images were captured from videotape using a Matrox capture board and Image-1 software (Universal Imaging, West Chester, PA). An onscreen caliper using a 100 × 0.01 = 1 mm stage micrometer (Graticules) was used for all calibrated dimensional measurements. Estimates of the anatomical capillary diameter were obtained from brightfield images using the imaging techniques described previously (6, 15). Measurements are dependent on careful selection of the vessel midplane, using care to neither underfocus nor overfocus the image of the capillary (6). The anatomical capillary diameter was then estimated by positioning digital calipers at the inside of the capillary wall (see Fig. 1). To correct for the thickness of the caliper bars, one of the calipers was positioned on the capillary wall with the luminal surface against the capillary lumen. The other caliper was positioned in the capillary lumen with its abluminal surface against the capillary wall. These estimates were compared with measurements of the fluorescent dye column after injection of the tracer. Estimates of the apparent thickness of the endothelial surface layer were obtained by subtracting the diameter of the dye column from the anatomical capillary diameter and dividing the difference by two. Prior measurements using this technique had shown good agreement between brightfield and fluorescence measurements made on beads of known size (6). Precision in these measurements was enhanced by repeated, paired measurements at a given site and by always referencing the brightfield measurement to the fluorescence determination. All values in Fig. 2 are means ± SE.
|
Experimental Protocols
All experimental protocols were started 45-60 min after completion of the hamster cremaster preparation. Measurement of capillary dimensions was made starting immediately after injection of the fluorescently labeled tracers.Images of randomly selected cremaster muscle capillaries were recorded on videotape during transillumination and epi-illumination (measurements made in random order). Care was taken to ensure that epi-illumination of an individual capillary was completed within a few seconds to minimize photo damage (15). As illustrated schematically in Fig. 1, the diameter of capillaries during transillumination was taken as an estimate of the anatomical capillary diameter. The diameter of the fluorescent tracer column in capillaries was measured during epi-illumination as an estimate of the functional capillary diameter available to the tracer molecules. Repeated, paired measurements of anatomical and functional capillary diameters were made for randomly selected capillaries at intervals of ~3 min for >3 h or until tracer intensity had equilibrated between the vascular lumen and the extravascular space.
| |
RESULTS |
|---|
|
|
|---|
Figure 2 shows time courses of movement of various tracers into the
endothelial surface layer. Data are shown for several dextrans and free
dyes (Fig. 2, A and B), for selected proteins (Fig.
2C), and for a protein-dextran complex (Fig. 2D).
Neutral and anionic dextran molecules with a molecular mass of
70 kDa remained fully excluded from the glycocalyx for >3 h. Smaller anionic
dye molecules and dextrans (mol. mass 0.4-40 kDa) invaded the coat
with size-dependent half-times between 11 and 60 min (Fig. 2, A
and B). For clarity, data on the 2,000- and 580-kDa molecules
are not shown because these did not penetrate the glycocalyx during the
time of observation and they followed a pattern indistinguishable from
that of the 70-kDa dye. Small neutral dye molecules and neutral dextrans equilibrated within the glycocalyx within a single capillary transit time (Fig. 2, A and B). This made adequate
quantitation of the rate of penetration impossible using the current
methodology. To ensure that the measurements of fluorescein- and
rhodamine-based dyes were comparable, in a few measurements the two
dyes were injected together. The patterns of dye movement were
identical to those shown in Fig. 2, A and B.
The dextrans are rather long, extended polymers with uniform charge groups occurring on ~1% of the glucose molecules. We also examined the movement into the glycocalyx of physiologically more relevant plasma proteins. Albumin [mol mass 67 kDa, isoelectric point (pI) 5.6] entered with a half-time of ~40 min. Surprisingly, fibrinogen (mol mass 340 kDa, pI 5.5) entered the endothelial surface layer at the same rate as albumin, though the molecular mass ratio would predict an entrance rate for fibrinogen 44% that of albumin (Fig. 2C). To more directly compare the entry patterns of proteins and dextrans we obtained a protein-dextran complex (albumin-Dex 70, Molecular Probes). Remarkably, the complex penetrated the endothelial surface layer with a half-time equivalent to that of albumin (Fig. 2D). This rate belies the fact that unbound Dextran 70 itself did not penetrate the glycocalyx for more than 3 h (Fig. 2A).
| |
DISCUSSION |
|---|
|
|
|---|
Our findings demonstrate that large dextran molecules (mol mass
70
kDa) remain restricted to the central core of hamster cremaster
capillaries for over 3 h, indicating that the endothelial surface layer (glycocalyx) is relatively impermeable to polysaccharides with effective radii
5.7 nm (10). Smaller dextrans and free dyes
permeated the endothelial surface layer at rates that depended on
molecular size and charge; half-times for anionic solutes (0.5-4.7 nm) were 11-60 min. It is important to recognize that charge and molecular weight of the dextrans vary in proportion to one another. There are roughly 0.6 fluorescein molecules per sugar in the dextrans (Sigma, unpublished data). The net charge on the proteins used to probe
the glycocalyx was not determined, and the variability in labeling
efficiency could be expected to cause significant variation in charge
in the labeled molecules. Thus although there is an obvious correlation
between both size and charge in these experiments, its exact nature at
this time cannot be specified because charge and size were not
systematically and independently varied.
Small neutral tracers penetrated the endothelial surface layer within a single capillary transit time. In contrast with the expected size-dependent behavior of anionic dextrans, protein entry rates did not follow predictions on the basis of their molecular mass. Uptake rates for two anionic plasma proteins, albumin (67 kDa) and fibrinogen (340 kDa), were similar despite an almost sixfold difference in molecular mass. Charge may have contributed to this unexpected similarity, though the pI for the two is reported to be the same. After labeling was completed, both would have had additional anionic groups added, but pIs of the labeled molecules were not determined because all the material was used in the animal experiments. The dextran-albumin complex (137 kDa) entered the endothelial surface layer at the same rate as native albumin (Fig. 2, C and D). This suggests that the passage of macromolecules into this space involves processes other than simple diffusion and highlights the need for systematic studies of the molecular structure of the glycocalyx. One interpretation of the observation is that the albumin can facilitate the entry of the large-molecular-weight dextran into the endothelial surface layer, a fact of major significance to our understanding of the transcapillary movement of macromolecules.
Size- and Charge-Dependent Hindrance of Macromolecular Penetration
Current transvascular exchange models predict an important role for the endothelial surface layer as a selective solute barrier (5, 13). These studies have shown that the classic pore model of exchange (12) must be extended to include polymer structures similar to those of the glycocalyx to allow consistent descriptions of transvascular pathways available to both water and solutes. It has been noted by Curry and Michel (5) that the presence of a matrix in or over the entrance to interendothelial gaps would hinder transport of solutes relatively more than water. The effect of this would be to reduce the apparent dimension of the solute exchange pathway from an equivalent pore radius of 8.0 to 5.5 nm (5). Our experimental data on mammalian capillaries in vivo show that dextrans with radii
5.7 nm do not appear to penetrate the endothelial surface layer, which is consistent with the theoretical prediction of the equivalent pore size.
In addition to the size-dependent hindrance of solute exchange, anionic
electrostatic charge distributions within the endothelial surface layer
are likely to further impair exchange of anionic solutes (7, 8, 11,
16). This is evidenced here by the slower diffusion rate of anionic
dextrans with radii
4.7 nm compared with neutral ones. These data are
also consistent with numerous previous findings on the solute charge
dependence of microvascular wall permeability (1, 10). We emphasize,
however, that our measurements are made on a structure extending well
into the vessel lumen, not one confined tightly to the cell surface.
The physiological significance of this barrier can be appreciated by
calculating the root-mean-square diffusion time for entry of albumin by
free diffusion into a 0.4-µm space (d2 =
4Dt; where d is the distance, D is the
diffusion coefficient, and t is the time). For a
molecule with a diffusion coefficient of 8.5 × 10
7, a value roughly equal to that for
albumin, the predicted diffusion time is 0.5 ms rather than the roughly
40 min observed. In any case, both theoretical predictions and our
experimental data strongly support the idea that that there is an
important role for the endothelial glycocalyx in creating a size- and
charge-selective exchange barrier associated with the microvessels.
Protein Interaction With Endothelial Surface Layer
The endothelial surface layer does not appear to be simply a size exclusion matrix, however. Although dextrans penetrated the matrix with a simple dependence on charge size, permeation by albumin (an albumin-dextran complex) and fibrinogen took place at indistinguishable rates; i.e., entry for these molecules does not follow a pattern that is predictable by size or charge alone. Although these solutes are all known to bear a net negative charge at physiological pH, their estimated radii are quite different, ranging between 3.7 and 10.8 nm for albumin and fibrinogen, respectively (2). Despite these differences in size, each of the solutes permeated the endothelial surface layer with a roughly the same half-time. We hypothesize that the similarity in uptake times reflects some specific interaction between the diffusing molecule and structures within the endothelial surface layer.| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: B. R. Duling, Dept. of Molecular Physiology and Biological Physics, Univ. of Virginia, Health Sciences Center, PO Box 10011, Charlottesville, VA 22906-0011 (E-mail: brd{at}virginia.edu).
Received 22 March 1999; accepted in final form 28 September 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adamson, R. H.,
V. H. Huxley,
and
F. E. Curry.
Single capillary permeability to proteins having similar size but different charge.
Am. J. Physiol. Heart Circ. Physiol.
254:
H304-H313,
1988
2.
Carter, R. D.,
W. L. Joyner,
and
E. M. Renkin.
Effects of histamine and some other substances on molecular sensitivity of the capillary wall to plasma proteins and dextran.
Microvasc. Res.
7:
31-48,
1974[Web of Science][Medline].
3.
Clough, G.
Relationship between microvascular permeability and ultrastructure.
Prog. Biophys. Mol. Biol.
55:
47-69,
1991[Web of Science][Medline].
4.
Curry, F. E.
Determinants of capillary permeability: a review of mechanisms based on single capillary studies in the frog.
Circ. Res.
59:
367-380,
1986
5.
Curry, F. E.,
and
C. C. Michel.
A fiber matrix model of capillary permeability.
Microvasc. Res.
20:
96-99,
1980[Web of Science][Medline].
6.
Gretz, J. E.,
and
B. R. Duling.
Measurement uncertainties associated with the use of bright-field and fluorescence microscopy in the microcirculation.
Microvasc. Res.
49:
134-140,
1995[Web of Science][Medline].
7.
Ito, S.
Structure and function of the glycocalyx.
Federation Proc.
28:
12-25,
1969[Web of Science][Medline].
8.
Kjellen, L.,
and
U. Lindahl.
Proteoglycans: structures and interactions.
Ann. Rev. Biochem.
60:
443-475,
1991[Web of Science][Medline].
9.
Levick, J. R.,
and
L. H. Smaje.
An analysis of the permeability of a fenestra.
Microvasc. Res.
33:
233-256,
1987[Web of Science][Medline].
10.
Leypoldt, J. K.,
and
L. W. Henderson.
Molecular charge influences transperitoneal macromolecule transport.
Kidney Int.
43:
837-844,
1993[Web of Science][Medline].
11.
Luft, J. H.
Fine structures of capillary and endocapillary layer as revealed by ruthenium red.
Federation Proc.
25:
1773-1783,
1966[Web of Science][Medline].
12.
Pappenheimer, J. R.,
E. M. Renkin,
and
L. M. Borrero.
Filtration, diffusion and molecular sieving through peripheral capillary membranes: a contribution to the pore theory of capillary permeability.
Am. J. Physiol.
167:
13-46,
1951.
13.
Renkin, E. M.
Cellular aspects of transvascular exchange: a 40-year perspective.
Microcirculation
1:
157-167,
1994[Medline].
14.
Schneeberger, E.,
R. D. Lynch,
and
B. A. Neary.
Interaction of native and chemically modified albumin with pulmonary microvascular endothelium.
Am. J. Physiol. Lung Cell. Mol. Physiol.
258:
L89-L98,
1990
15.
Vink, H.,
and
B. R. Duling.
Identification of distinct domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries.
Circ. Res.
79:
581-589,
1996
16.
Vink, H.,
P. A. Wieringa,
and
J. A. E. Spaan.
Evidence that cell surface charge reduction modifies capillary red cell velocity-flux relationships in hamster cremaster muscle.
J. Physiol. (Lond.)
489:
193-201,
1995
This article has been cited by other articles:
![]() |
P. Cabrales, G. Sun, Y. Zhou, D. R. Harris, A. G. Tsai, M. Intaglietta, and A. F. Palmer Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction J Appl Physiol, November 1, 2009; 107(5): 1548 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wills, T. Van Ngoc, N. T. H. Van, T. T. T. Thuy, T. T. N. Thuy, N. M. Dung, T. V. Diet, N. Van Vinh Chau, D. T. Trung, and J. Farrar Hemostatic Changes in Vietnamese Children with Mild Dengue Correlate with the Severity of Vascular Leakage Rather than Bleeding Am J Trop Med Hyg, October 1, 2009; 81(4): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tarbell and E. E. Ebong The Endothelial Glycocalyx: A Mechano-Sensor and -Transducer Sci. Signal., October 7, 2008; 1(40): pt8 - pt8. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rippe Free water transport, small pore transport and the osmotic pressure gradient three-pore model of peritoneal transport Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2147 - 2153. [Full Text] [PDF] |
||||
![]() |
M. F. Flessner Distributed model of peritoneal transport: implications of the endothelial glycocalyx Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2142 - 2146. [Full Text] [PDF] |
||||
![]() |
J. W. G. E. VanTeeffelen, A. A. Constantinescu, J. Brands, J. A. E. Spaan, and H. Vink Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties J. Physiol., July 1, 2008; 586(13): 3207 - 3218. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Haraldsson, J. Nystrom, and W. M. Deen Properties of the Glomerular Barrier and Mechanisms of Proteinuria Physiol Rev, April 1, 2008; 88(2): 451 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nieuwdorp, M. C. Meuwese, H. L. Mooij, C. Ince, L. N. Broekhuizen, J. J. P. Kastelein, E. S. G. Stroes, and H. Vink Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability J Appl Physiol, March 1, 2008; 104(3): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. J. Salmon, I. Toma, A. Sipos, P. R. Muston, S. J. Harper, D. O. Bates, C. R. Neal, and J. Peti-Peterdi Evidence for restriction of fluid and solute movement across the glomerular capillary wall by the subpodocyte space Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1777 - F1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Stevens, V. Hlady, and R. O. Dull Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L328 - L335. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yao, A. Rabodzey, and C. F. Dewey Jr. Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1023 - H1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W.G.E. VanTeeffelen, J. Brands, C. Jansen, J. A.E. Spaan, and H. Vink Heparin Impairs Glycocalyx Barrier Properties and Attenuates Shear Dependent Vasodilation in Mice Hypertension, July 1, 2007; 50(1): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cabrales, B. Y. S. Vazquez, A. G. Tsai, and M. Intaglietta Microvascular and capillary perfusion following glycocalyx degradation J Appl Physiol, June 1, 2007; 102(6): 2251 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jacob, P. Conzen, U. Finsterer, A. Krafft, B. F. Becker, and M. Rehm Technical and physiological background of plasma volume measurement with indocyanine green: a clarification of misunderstandings J Appl Physiol, March 1, 2007; 102(3): 1235 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bjornson Granqvist, K. Ebefors, M. A. Saleem, P. W. Mathieson, B. Haraldsson, and J. S. Nystrom Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome Am J Physiol Renal Physiol, October 1, 2006; 291(4): F722 - F730. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. van den Berg and H. Vink Glycocalyx perturbation: cause or consequence of damage to the vasculature? Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2174 - H2175. [Full Text] [PDF] |
||||
![]() |
I. Rubio-Gayosso, S. H. Platts, and B. R. Duling Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nieuwdorp, H. L. Mooij, J. Kroon, B. Atasever, J. A.E. Spaan, C. Ince, F. Holleman, M. Diamant, R. J. Heine, J. B.L. Hoekstra, et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes, April 1, 2006; 55(4): 1127 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, D. Jaron, K. A. Barbee, and D. G. Buerk The influence of radial RBC distribution, blood velocity profiles, and glycocalyx on coupled NO/O2 transport J Appl Physiol, February 1, 2006; 100(2): 482 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jeansson and B. Haraldsson Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier Am J Physiol Renal Physiol, January 1, 2006; 290(1): F111 - F116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gouverneur, J. A. E. Spaan, H. Pannekoek, R. D. Fontijn, and H. Vink Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H458 - H452. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. A. van Haaren, E. VanBavel, H. Vink, and J. A. E. Spaan Charge modification of the endothelial surface layer modulates the permeability barrier of isolated rat mesenteric small arteries Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2503 - H2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. G. E. VanTeeffelen, S. Dekker, D. S. Fokkema, M. Siebes, H. Vink, and J. A. E. Spaan Hyaluronidase treatment of coronary glycocalyx increases reactive hyperemia but not adenosine hyperemia in dog hearts Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2508 - H2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Pries and T. W. Secomb Microvascular blood viscosity in vivo and the endothelial surface layer Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2657 - H2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bruegger, M. Jacob, M. Rehm, M. Loetsch, U. Welsch, P. Conzen, and B. F. Becker Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1993 - H1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Zuurbier, C. Demirci, A. Koeman, H. Vink, and C. Ince Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells J Appl Physiol, October 1, 2005; 99(4): 1471 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ono, R. Mizuno, and T. Ohhashi Effective permeability of hydrophilic substances through walls of lymph vessels: roles of endothelial barrier Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1676 - H1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Wills, N. M. Dung, H. T. Loan, D. T.H. Tam, T. T.N. Thuy, L. T.T. Minh, T. V. Diet, N. T. Hao, N. V. Chau, K. Stepniewska, et al. Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome N. Engl. J. Med., September 1, 2005; 353(9): 877 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Flessner The transport barrier in intraperitoneal therapy Am J Physiol Renal Physiol, March 1, 2005; 288(3): F433 - F442. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ueda, M. Shimomura, M. Ikeda, R. Yamaguchi, and K. Tanishita Effect of glycocalyx on shear-dependent albumin uptake in endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2287 - H2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Mulivor and H. H. Lipowsky Inflammation- and ischemia-induced shedding of venular glycocalyx Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1672 - H1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Platts and B. R. Duling Adenosine A3 Receptor Activation Modulates the Capillary Endothelial Glycocalyx Circ. Res., January 9, 2004; 94(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. A. van Haaren, E. VanBavel, H. Vink, and J. A. E. Spaan Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2848 - H2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Florian, J. R. Kosky, K. Ainslie, Z. Pang, R. O. Dull, and J. M. Tarbell Heparan Sulfate Proteoglycan Is a Mechanosensor on Endothelial Cells Circ. Res., November 14, 2003; 93 (10): e136 - e142. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-D. Mi, H. Ishihara, T. Sakai, and A. Matsuki Possible Overestimation of Indocyanine Green-Derived Plasma Volume Early After Induction of Anesthesia with Propofol/Fentanyl Anesth. Analg., November 1, 2003; 97(5): 1421 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mochizuki, H. Vink, O. Hiramatsu, T. Kajita, F. Shigeto, J. A. E. Spaan, and F. Kajiya Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H722 - H726. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Platts, J. Linden, and B. R. Duling Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2360 - H2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gonzalez-Castillo, R. Rubio, and T. Zenteno-Savin Coronary flow-induced inotropism is modulated by binding of dextrans to the endothelial luminal surface Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1348 - H1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sorensson, A. Bjornson, M. Ohlson, B. J. Ballermann, and B. Haraldsson Synthesis of sulfated proteoglycans by bovine glomerular endothelial cells in culture Am J Physiol Renal Physiol, February 1, 2003; 284(2): F373 - F380. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Mulivor and H. H. Lipowsky Role of glycocalyx in leukocyte-endothelial cell adhesion Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1282 - H1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Osterloh, U. Ewert, and A. R. Pries Interaction of albumin with the endothelial cell surface Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H398 - H405. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. J. M. F. Willemsen, D. J. Duncker, R. Krams, M. A. Dijkman, R. R. Lamberts, P. Sipkema, and N. Westerhof Decrease in coronary vascular volume in systole augments cardiac contraction Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H731 - H737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Constantinescu, H. Vink, and J. A. E. Spaan Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1051 - H1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. S. Henry and B. R. Duling TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2815 - H2823. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |